Gastrointestinal: The duodenum on and off olmesartan

J Gastroenterol Hepatol. 2021 Jun;36(6):1388. doi: 10.1111/jgh.15345. Epub 2020 Dec 10.

Authors

V Zimmer^{1

2}, K Emrich³

Affiliations

¹ Department of Medicine, Marienhausklinik St. Josef Kohlhof, Neunkirchen, Germany.
² Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.
³ Insitute of Pathology Saarbrücken-Rastpfuhl, Saarbrücken, Germany.

PMID: 33305468
DOI: 10.1111/jgh.15345

No abstract available

Publication types

Case Reports
Review

MeSH terms

Aged, 80 and over
Angiotensin II Type 1 Receptor Blockers* / adverse effects
Angiotensin II Type 1 Receptor Blockers* / pharmacology
Biopsy
Chronic Disease
Diarrhea* / chemically induced
Duodenum* / drug effects
Duodenum* / pathology
Duodenum* / surgery
Endoscopy, Digestive System
Humans
Imidazoles* / adverse effects
Imidazoles* / pharmacology
Male
Tetrazoles* / adverse effects
Tetrazoles* / pharmacology

Substances

Angiotensin II Type 1 Receptor Blockers
Imidazoles
Tetrazoles
olmesartan